Skip to main content
logo
Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
6.66
-0.38 (-5.40%)
At close: Mar 27, 2026, 4:00 PM EDT
6.57
-0.09 (-1.35%)
After-hours: Mar 27, 2026, 7:50 PM EDT

Aligos Therapeutics Revenue

In the year 2025, Aligos Therapeutics had annual revenue of $2.19M, down -44.59%. Aligos Therapeutics had revenue of $169.00K in the quarter ending December 31, 2025, a decrease of -73.13%.

Revenue (ttm)
$2.19M
Revenue Growth
-44.59%
P/S Ratio
18.85
Revenue / Employee
$26,659
Employees
82
Market Cap
41.21M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20252.19M-1.76M-44.59%
Dec 31, 20243.95M-11.58M-74.60%
Dec 31, 202315.53M1.62M11.66%
Dec 31, 202213.91M9.55M219.04%
Dec 31, 20214.36M--
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Atara Biotherapeutics120.77M
NovaBay Pharmaceuticals10.30M
Plus Therapeutics5.21M
Werewolf Therapeutics1.14M
Rallybio858.00K
Lisata Therapeutics170.00K
Revenue Rankings

ALGS News

More News